• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness.药物性肝损伤的侦探工作:有时关键在于采访合适的证人。
Clin Gastroenterol Hepatol. 2010 Jul;8(7):635-7. doi: 10.1016/j.cgh.2010.03.020. Epub 2010 Apr 2.
2
Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.冰岛普通人群中药物性肝损伤患者的发病情况、临床表现和转归。
Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006. Epub 2013 Feb 16.
3
Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.经 Roussel Uclaf 因果关系评估方法评估的 3312 例药物性肝损伤病例中的排名前位药物。
Expert Opin Drug Metab Toxicol. 2018 Nov;14(11):1169-1187. doi: 10.1080/17425255.2018.1539077. Epub 2018 Oct 29.
4
Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.COVID-19 患者药物性肝损伤:基于 RUCAM 因果关系评估方法,对 2020/2021 年发表的 996 例 DILI 病例的系统评价。
Int J Mol Sci. 2022 Apr 27;23(9):4828. doi: 10.3390/ijms23094828.
5
Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.避免药物性肝损伤(DILI)在一个老年住院队列中,使用更新的 RUCAM 评分评估因果关系的病例。
BMC Geriatr. 2020 Sep 14;20(1):346. doi: 10.1186/s12877-020-01732-3.
6
Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.计算机化 ICD-10 算法在电子病历中识别特发性药物性肝损伤病例的效用。
Drug Saf. 2020 Apr;43(4):371-377. doi: 10.1007/s40264-019-00903-5.
7
Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.住院患者中显著升高的丙氨酸氨基转移酶与药物性肝损伤。
World J Gastroenterol. 2012 Nov 7;18(41):5972-8. doi: 10.3748/wjg.v18.i41.5972.
8
A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.一种利用日本诊断量表在医学信息数据库中检测药物性肝损伤的算法及其与国际医学科学组织理事会/鲁塞尔·优克福因果关系评估方法量表的比较
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):984-8. doi: 10.1002/pds.3603. Epub 2014 Mar 5.
9
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.药物性肝损伤的因果关系评估:采用结构化专家意见程序与 Roussel-Uclaf 因果关系评估方法的比较。
Hepatology. 2010 Jun;51(6):2117-26. doi: 10.1002/hep.23577.
10
Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.有重大医学合并症的患者,其疑似药物性肝损伤的因果关系评分较低。
Clin Transl Gastroenterol. 2020 Apr;11(4):e00141. doi: 10.14309/ctg.0000000000000141.

引用本文的文献

1
Recent advances in the diagnosis of drug-induced liver injury.药物性肝损伤诊断的最新进展。
World J Hepatol. 2024 Feb 27;16(2):186-192. doi: 10.4254/wjh.v16.i2.186.
2
When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.当疑似药物性肝损伤(DILI)不是 DILI 时该怎么办?来自药物性肝损伤网络的不太可能的病例分析。
Am J Gastroenterol. 2023 Dec 1;118(12):2301-2304. doi: 10.14309/ajg.0000000000002370. Epub 2023 Jun 14.
3
Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury.草药性肝损伤的诊断和管理指南。
Chin J Integr Med. 2018 Sep;24(9):696-706. doi: 10.1007/s11655-018-3000-8. Epub 2018 Mar 15.
4
Research Advances on Hepatotoxicity of Herbal Medicines in China.中国草药肝毒性的研究进展
Biomed Res Int. 2016;2016:7150391. doi: 10.1155/2016/7150391. Epub 2016 Dec 18.
5
Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.直接作用抗病毒药物相关肝损伤后丙型肝炎病毒治愈:病例报告
World J Hepatol. 2016 Jul 18;8(20):858-62. doi: 10.4254/wjh.v8.i20.858.
6
Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum.基于证据链的肝损伤中药相关性鉴定:以著名的肝修复中药何首乌为例。
Front Med. 2015 Dec;9(4):457-67. doi: 10.1007/s11684-015-0417-8. Epub 2015 Oct 12.
7
Cholestatic hepatitis with small duct injury associated with celecoxib.与塞来昔布相关的伴有小胆管损伤的胆汁淤积性肝炎。
Case Rep Med. 2013;2013:315479. doi: 10.1155/2013/315479. Epub 2013 Jun 5.

本文引用的文献

1
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.药物性肝损伤网络(DILIN)前瞻性研究:原理、设计与实施。
Drug Saf. 2009;32(1):55-68. doi: 10.2165/00002018-200932010-00005.
2
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.美国药物性肝损伤前瞻性研究的病因、临床特征及结果
Gastroenterology. 2008 Dec;135(6):1924-34, 1934.e1-4. doi: 10.1053/j.gastro.2008.09.011. Epub 2008 Sep 17.
3
Acute liver failure: Summary of a workshop.急性肝衰竭:研讨会总结
Hepatology. 2008 Apr;47(4):1401-15. doi: 10.1002/hep.22177.
4
Alfuzosin-induced acute liver injury.
Korean J Hepatol. 2007 Sep;13(3):414-8. doi: 10.3350/kjhep.2007.13.3.414.
5
Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.阿莫西林-克拉维酸肝毒性临床表型的决定因素:来自西班牙的一项前瞻性研究系列
Hepatology. 2006 Oct;44(4):850-6. doi: 10.1002/hep.21324.
6
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.急性肝衰竭患者血清对乙酰氨基酚 - 蛋白质加合物的测定。
Gastroenterology. 2006 Mar;130(3):687-94. doi: 10.1053/j.gastro.2006.01.033.
7
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.对乙酰氨基酚所致急性肝衰竭:一项美国多中心前瞻性研究的结果
Hepatology. 2005 Dec;42(6):1364-72. doi: 10.1002/hep.20948.
8
Alfuzosin-induced acute hepatitis in a patient with chronic liver disease.阿夫唑嗪致一名慢性肝病患者发生急性肝炎。
Ann Pharmacother. 2004 Sep;38(9):1443-5. doi: 10.1345/aph.1D633. Epub 2004 Jul 27.
9
Alfuzosin-induced hepatotoxicity.阿夫唑嗪诱发的肝毒性。
J Clin Pharm Ther. 2000 Feb;25(1):73-4. doi: 10.1046/j.1365-2710.2000.00259.x.
10
Phenytoin as a possible cause of acetaminophen hepatotoxicity: case report and review of the literature.
Pharmacotherapy. 2000 Feb;20(2):229-33. doi: 10.1592/phco.20.3.229.34774.

药物性肝损伤的侦探工作:有时关键在于采访合适的证人。

Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness.

机构信息

Division of Gastroenterology and Hepatology, Liver Program, University of North Carolina, Chapel Hill, North Carolina 27599-7584, USA.

出版信息

Clin Gastroenterol Hepatol. 2010 Jul;8(7):635-7. doi: 10.1016/j.cgh.2010.03.020. Epub 2010 Apr 2.

DOI:10.1016/j.cgh.2010.03.020
PMID:20363371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3292181/
Abstract

Diagnosing drug-induced liver injury (DILI) relies primarily on history taking. We report 4 cases in which DILI was missed or the drug was misidentified when physicians relied solely on patient history. We reviewed 27 cases referred with possible DILI from August 1, 2009, to February 1, 2010. Four patients seemed to be reliable historians, but their cases were greatly clarified by a call to their pharmacist. One subject, who forgot a new medication, underwent an unfruitful evaluation including surgery. Another patient had acetaminophen toxicity that was missed because she grossly underreported her pain medication use. The third and fourth patients forgot taking amoxicillin/clavulanate, so other agents mistakenly were implicated. Roussel Uclaf Causality Assessment Method scores were 8 (probable) or 9 (highly probable) for all 4 cases. Without pharmacy input, DILI was missed in 2 cases and the wrong agent was implicated twice. Reviewing pharmacy records can be crucial for patients and DILI research. We recommend calling the pharmacist directly for increased liver enzyme levels of unclear source or suspected DILI regardless of patient history.

摘要

诊断药物性肝损伤(DILI)主要依赖于病史采集。我们报告了 4 例病例,当医生仅依赖于患者病史时,这些病例被误诊或药物被错误识别。我们回顾了 2009 年 8 月 1 日至 2010 年 2 月 1 日期间转诊的 27 例疑似 DILI 病例。这 4 名患者似乎都是可靠的病史提供者,但通过与他们的药剂师通话,他们的病例得到了很大的澄清。一名患者忘记了一种新的药物,尽管进行了包括手术在内的无效评估。另一名患者因严重低估了自己的止痛药物使用量而导致对乙酰氨基酚中毒被漏诊。第三和第四位患者忘记服用阿莫西林/克拉维酸钾,因此错误地涉及到了其他药物。所有 4 例病例的 Roussel Uclaf 因果关系评估方法评分均为 8(可能)或 9(高度可能)。如果没有药剂师的意见,2 例病例被误诊,而且错误地涉及到了两种药物。对于不明原因或疑似 DILI 的肝酶水平升高的患者,无论其病史如何,我们建议直接与药剂师联系,这对患者和 DILI 研究都至关重要。